Senior insider sale
Chief Financial Officer at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$89.4K
21.38K shares
What this filing means
TAYLOR BEN R plans to sell 21.38K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $89.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001959173-25-007926
Officer· Chief Financial Officer
Since Feb 2026
21.38K
Shares to sell
$89.4K
Approx. market value
21.38K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
12/15/2025
7.96KRestricted Stock Vesting
Compensation
11/15/2025
13.43KTotal acquired21.38K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2025 | Restricted Stock Vesting Compensation | 7.96K | — |
11/15/2025 | Restricted Stock Vesting Compensation | 13.43K | — |
| Total | 21.38K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
21.38K
Market value
$89.4K
12/29/2025
Total
Units
21.38K
Value
$89.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/29/2025 | 21.38K | $89.4K | NASDAQ | Planned |
| Total | 21.38K | $89.4K | ||